Clinical Trials · NCT07302802
Efficacy of Semaglutide s.c. Once-weekly on Weight Loss and Management in Adolescents With Monogenic Obesity in Clinical Practice
- Phase
- N/A
- Recruitment status
- Recruiting
- Sponsor
- Prof. Dr. Martin Wabitsch
- Enrollment
- 70
- Start date
- Dec 2025
- Locations
- 7 sites, 5 countries
- Primary endpoint
- Proportion of participants achieving ≥10% BMI reduction from baseline (week 0) to week 68.